[ad_1]
Two people with a history of severe allergy suffered anaphylactic shock, but were medicated when they took the covid vaccine on the first day of immunization.
UK issues warning after allergic reaction to Pfizer vaccine
-
09/12/2020 – 09h50 (Updated 09/12/2020 – 10h30)
Two people who were immunized against covid-19 on Tuesday (8) in England with the Pfizer / BioNTech vaccine suffered a severe allergic reaction, prompting British regulatory agencies to advise people with a history of severe allergies not to get vaccinated.
The National Health Service (NHS) of England confirmed on Wednesday (9) that two health professionals suffered an allergic reaction after receiving the first of two doses of the vaccine, on the first day of the British vaccination program against covid -19.
Also read: ‘Superfungal’ on alert in Brazil worries, but not a threat such as covid-19, says infectologist
The MHRA (Medicines and Health Products Regulatory Agency) has issued an alert for those who have severe allergic reactions to drugs, foods, or other vaccines that bypass the immunizer.
England’s NHS said that all English hospitals participating in the program have been informed.
Regulators ask that the centers where the vaccines are administered have adequate facilities to help those affected in case of any type of reaction.
These two health professionals appear to have a clinical history of severe allergies as they were carrying adrenaline auto-injectors, British media reported on Wednesday (9).
Shortly after being vaccinated, the two health professionals suffered anaphylactic shock, but recovered as soon as they received appropriate treatment, according to health authorities.
This type of reaction is sudden and generalized, usually beginning with a tingling sensation and dizziness.
Vaccinations started on Tuesday (8) in 50 major UK hospitals, on what the government called “V Day” (vaccination day).
The first doses are aimed at people over 80 years of age, health workers and nursing homes, although they have to wait for the logistics to allow the transfer of the vaccine.
The UK has bought 40 million doses, which will immunize 20 million people.
